<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26945363</article-id>
      <article-id pub-id-type="pmc">4782847</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000002813</article-id>
      <article-id pub-id-type="art-access-id">02813</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>4900</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Multiple Brain Abscesses Due to <italic>Aspergillus Fumigatus</italic> in a Patient With Liver Cirrhosis</article-title>
        <subtitle>A Case Report</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>Hung-Jen</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Wei-Lun</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chang</surname>
            <given-names>Tsung Chain</given-names>
          </name>
          <degrees>PhD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Ming-Chi</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ko</surname>
            <given-names>Wen-Chien</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Chi-Jung</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chuang</surname>
            <given-names>Yin-Ching</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lai</surname>
            <given-names>Chih-Cheng</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Elfaki.</surname>
            <given-names>Mohamed</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>From the Department of Medicine (H-JT), Chi Mei Medical Center, Tainan, and Department of Health and Nutrition, Chia Nan University of Pharmacy and Science, Tainan; Department of Intensive Care Medicine (WWL, CCL), Chi Mei Medical Center, Liouying, Tainan; Department of Medical Laboratory Science and Biotechnology (TCC), College of Medicine, National Cheng Kung University, Tainan; Department of Internal Medicine (M-CL, W-CK, C-JW), National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan; National Institute of Infectious Diseases and Vaccinology (C-JW), National Health Research Institutes, Tainan; Department of Medical Research (Y-CC), Chi Mei Medical Center, Tainan; and Department of Internal Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan.</aff>
      <author-notes>
        <corresp>Correspondence: Chih-Cheng Lai, Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan (e-mail: <email>dtmed141@gmail.com).</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>07</day>
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>9</issue>
      <elocation-id>e2813</elocation-id>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nd/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nd/4.0">http://creativecommons.org/licenses/by-nd/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e2813.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Invasive cerebral aspergillosis always developed in immunocompromised host. Early diagnosis may save life in this critical condition; however, it is difficult to reach. Herein, we presented an unusual case of invasive cerebral aspergillosis in a cirrhotic patient.</p>
        <p>A 47-year-old man presented with progressive deterioration of consciousness for three days. The patient had a history of alcoholic liver cirrhosis, Child-Pugh class C. Magnetic resonance imaging (MRI) of brain showed multi-focal parenchymal lesions, which was consistent with multiple brain abscesses. The diagnosis of invasive cerebral aspergillosis was made by molecular based laboratory methods including Aspergillus galactomannan antigen assay and oligonucleotide array. Despite treatment with the antifungal agent, Amphotericin B, the patient died at the ninth day of hospitalization.</p>
        <p>Our findings suggest that liver cirrhosis can be one of risk factors of invasive cerebral aspergillosis, and support the diagnosing usefulness of MRI, Aspergillus galactomannan antigen assay, and oligonucleotide array.</p>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Invasive cerebral aspergillosis usually developed in immunocompromised host.<sup><xref rid="R1" ref-type="bibr">1</xref>&#x2013;<xref rid="R3" ref-type="bibr">3</xref></sup> Early diagnosis may save life in this critical condition; however, it is difficult to reach. Herein, we presented an unusual case of invasive cerebral aspergillosis that was diagnosed by image, and molecular-based laboratory methods.</p>
    </sec>
    <sec>
      <title>CASE PRESENTATION</title>
      <p>A 47-year-old man presented with progressive deterioration of consciousness for 3 days. The patient had a history of alcoholic liver cirrhosis, Child-Pugh class C. On arrival, his vital signs were as follows: a temperature of 38.2&#xB0;C, pulse rate of 112/min, respiratory rate of 23/min, and blood pressure of 115/74 mm Hg. Laboratory examinations were as follows: white cell count 22900/mm<sup>3</sup>, platelet 52000/mm<sup>3</sup>, creatinine 0.86 mg/dL, asparate aminotransferase 55 IU/L, sodium 130 mmol/L, glucose 151 mg/dL, ammonia, 30 umol/L, C-reactive protein of 89 mg/L (reference value &lt;3 mg/L). Radiography of the chest revealed multiple patches over bilateral peripheral lung fields. Computed tomography of brain did not disclose any evidence of intracerebral hemorrhage. Magnetic resonance imaging (MRI) of brain showed multifocal parenchymal lesions with signal change involving subcortical regions of bilateral superior frontal gyri, left lateral occipital gyrus, bilateral cerebellar parenchyma, and left lenticular nucleus (Figure <xref ref-type="fig" rid="F1">1</xref>), which was consistent with multiple brain abscesses. In support of our clinical diagnosis, we used ELISA and PCR to detect <italic>Aspergillus</italic> antigen and DNA, respectively. Cerebrospinal fluid (CSF) Platelia <italic>Aspergillus</italic> galactomannan antigen test showed a value of optical density index &gt;7.46. However, for the PCR we used oligonucleotide array for rapid screening in which the gold standard for <italic>Aspergillus</italic> species confirmation relies on the internal transcribed spacer sequencing and the 28s rDNA sequencing.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> In this case, the internal transcribed spacer result was <italic>Aspergillus fumigatus</italic> 99.5% (549/552) and 28s rDNA sequencing result was <italic>A fumigatus</italic> 99.5% (578/581). At the same time, the culture of sputum specimen grew <italic>A fumigatus</italic>, and serum <italic>Aspergillus</italic> galactomannan antigen test also showed a positive result (optical density index&#x200A;&#x2265;&#x200A;0.5). Despite treatment with the antifungal agent, Amphotericin B, the patient had rapidly developed shock with acute respiratory failure. The patient died at the ninth day of hospitalization. However, eventual fungal culture results of CSF remain negative after 4 weeks.</p>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Magnetic resonance imaging showed multifocal parenchymal lesions with hemorrhage in the brain (arrows).</p>
        </caption>
        <graphic xlink:href="medi-95-e2813-g001"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Invasive cerebral aspergillosis is an uncommon disease, and most of reported cases developed in severe immunodeficiency patients, such as transplant recipients, steroid users, and cancer patients.<sup><xref rid="R1" ref-type="bibr">1</xref>&#x2013;<xref rid="R3" ref-type="bibr">3</xref></sup> In contrast, liver cirrhosis&#x2014;the only one immunocompromised condition for the present case&#x2014;is not traditionally considered an important risk factor of invasive cerebral aspergillosis. Based on a literature search in PubMed/Medline, Jeurissen et al<sup><xref rid="R5" ref-type="bibr">5</xref></sup> identified only a total of 43 cases with cirrhosis and/or liver failure who have developed invasive aspergillosis between 2002 and 2012. Among them, lung was the most frequent organ involved (n&#x200A;=&#x200A;42), whereas other organs including skin, esophagus, pericardium, myocardium, stomach, kidney, and brain were less involved with only 7 patients being reported. Although invasive aspergillosis rarely develops in cirrhotic patients without conventional risk factors, our report and previous studies<sup><xref rid="R5" ref-type="bibr">5</xref>&#x2013;<xref rid="R7" ref-type="bibr">7</xref></sup> should suggest that clinicians should keep in mind this possible invasive aspergillosis, including aspergillus brain abscess as possible differential diagnosis among patients with liver cirrhosis.</p>
      <p>Because the clinical manifestations of intracerebral aspergillosis are nonspecific, early diagnosis to prompt direct treatment is difficult. However, other options for early diagnosis of invasive aspergillosis should be explored. Ideally, culture of sterile CSF specimen is the method of choice and is considered the &#x201C;gold standard&#x201D; for definitive diagnosis. Current methods to obtain CSF specimen from this critically ill patient were hindered unless an aggressive, risky, and invasive approach is exercised. Alternatively, MRI and molecular diagnostic methods offered an attractive approach that helped us to save the life of this patient and to reach a definitive diagnosis in speedy manner.<sup><xref rid="R4" ref-type="bibr">4</xref></sup> In our case, characteristic MRI findings of <italic>Aspergillus</italic> brain abscess, and the positive <italic>Aspergillus</italic> galactomannan antigen assay provided useful information in diagnosing invasive aspergillosis. In addition, a supportive test, oligonucleotide array, had helped us to accurately and rapidly identify the mycotic infection to the species level as <italic>A fumigatus</italic>. Based on these findings, it is evident that using oligonucleotide array test can make the diagnosis of invasive aspergillosis more easy and rapid than before. However, the unavailability of this test constrains its application as a diagnostic method of choice in conventional laboratories.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>CONCLUSIONS</title>
      <p>Our findings suggest that liver cirrhosis can be one of risk factors of invasive cerebral aspergillosis and support the diagnosing usefulness of MRI, <italic>Aspergillus</italic> galactomannan antigen assay, and oligonucleotide array.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: CSF = cerebrospinal fluid, MRI = magnetic resonance imaging.</p>
      </fn>
      <fn fn-type="other">
        <p>Informed consent: The patient's family has given written informed consent for the case to be reported. Because it was not a clinical trial and no off-label drugs were used, the ethical approval is not necessary for this case report.</p>
      </fn>
      <fn fn-type="conflict">
        <p>The authors have no conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhury</surname><given-names>N</given-names></name><name><surname>Khan</surname><given-names>AB</given-names></name><name><surname>Tzvetanov</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Multiple Aspergillus brain abscesses after liver transplantation</article-title>. <source><italic>Transplantation</italic></source>
<year>2014</year>; <volume>97</volume>:<fpage>e72</fpage>&#x2013;<lpage>e73</lpage>.<pub-id pub-id-type="pmid">24933254</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhaskar</surname><given-names>N</given-names></name><name><surname>Mohammad</surname><given-names>K</given-names></name><name><surname>Kaur</surname><given-names>V</given-names></name></person-group>
<article-title>Aspergillus brain abscess</article-title>. <source><italic>J Ark Med Soc</italic></source>
<year>2013</year>; <volume>110</volume>:<fpage>41</fpage>&#x2013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">24015447</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>G</given-names></name><name><surname>Thulkar</surname><given-names>S</given-names></name><name><surname>Arava</surname><given-names>SK</given-names></name><etal/></person-group>
<article-title>Cerebral aspergillus infection in pediatric acute lymphoblastic leukemia induction therapy</article-title>. <source><italic>Indian J Med Paediatr Oncol</italic></source>
<year>2012</year>; <volume>33</volume>:<fpage>236</fpage>&#x2013;<lpage>238</lpage>.<pub-id pub-id-type="pmid">23580827</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>CR</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Bouchara</surname><given-names>JP</given-names></name><etal/></person-group>
<article-title>Identification of medically important molds by an oligonucleotide array</article-title>. <source><italic>J Clin Microbiol</italic></source>
<year>2005</year>; <volume>43</volume>:<fpage>3760</fpage>&#x2013;<lpage>3768</lpage>.<pub-id pub-id-type="pmid">16081907</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeurissen</surname><given-names>S</given-names></name><name><surname>Vogelaers</surname><given-names>D</given-names></name><name><surname>Sermijn</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Invasive aspergillosis in patients with cirrhosis, a case report and review of the last 10 years</article-title>. <source><italic>Acta Clin Belg</italic></source>
<year>2013</year>; <volume>68</volume>:<fpage>368</fpage>&#x2013;<lpage>375</lpage>.<pub-id pub-id-type="pmid">24579244</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>P</given-names></name><name><surname>Thurnheer</surname><given-names>R</given-names></name><name><surname>Moll</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Invasive aspergillosis in non-neutropenic patients</article-title>. <source><italic>Eur J Intern Med</italic></source>
<year>2009</year>; <volume>20</volume>:<fpage>e131</fpage>&#x2013;<lpage>e133</lpage>.<pub-id pub-id-type="pmid">19782903</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Hospital-acquired invasive pulmonary aspergillosis in patients with hepatic failure</article-title>. <source><italic>BMC Gasstroenterol</italic></source>
<year>2008</year>; <volume>8</volume>:<fpage>32</fpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
